Does the media prefer DH or AMWL?

In the previous week, Definitive Healthcare had 1 more articles in the media than American Well. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for American Well. American Well's average media sentiment score of 0.88 beat Definitive Healthcare's score of 0.82 indicating that American Well is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive American Well 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to OPRX or DH?

In the previous week, OptimizeRx and OptimizeRx both had 3 articles in the media. OptimizeRx's average media sentiment score of 0.93 beat Definitive Healthcare's score of 0.82 indicating that OptimizeRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HCAT or DH?

In the previous week, Definitive Healthcare had 1 more articles in the media than Health Catalyst. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.91 beat Definitive Healthcare's score of 0.82 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DRIO or DH?

In the previous week, DarioHealth and DarioHealth both had 3 articles in the media. DarioHealth's average media sentiment score of 1.00 beat Definitive Healthcare's score of 0.82 indicating that DarioHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Definitive Healthcare (DH) Competitors

$1.03 -0.02 (-1.43%)

As of 12:59 PM Eastern

Compare

DH vs. AMWL, OPRX, HCAT, CCLD, and DRIO

Should you buy Definitive Healthcare stock or one of its competitors? Definitive Healthcare's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), CareCloud (CCLD), and DarioHealth (DRIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Definitive Healthcare compare to American Well?

Definitive Healthcare (NASDAQ:DH) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Definitive Healthcare presently has a consensus price target of $1.47, suggesting a potential upside of 42.17%. American Well has a consensus price target of $9.50, suggesting a potential downside of 30.43%. Given Definitive Healthcare's higher probable upside, research analysts plainly believe Definitive Healthcare is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Definitive Healthcare has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, American Well has a beta of 1.71, suggesting that its stock price is 71% more volatile than the broader market.

In the previous week, Definitive Healthcare had 1 more articles in the media than American Well. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for American Well. American Well's average media sentiment score of 0.88 beat Definitive Healthcare's score of 0.82 indicating that American Well is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

American Well has a net margin of -35.75% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
American Well	-35.75%	-30.12%	-22.30%

American Well has higher revenue and earnings than Definitive Healthcare. American Well is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A
American Well	$249.32M	0.91	-$95.70M	-$4.77	N/A

Summary

Definitive Healthcare beats American Well on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

OptimizeRx has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

OptimizeRx presently has a consensus target price of $11.43, indicating a potential upside of 46.61%. Definitive Healthcare has a consensus target price of $1.47, indicating a potential upside of 42.17%. Given OptimizeRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe OptimizeRx is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

OptimizeRx has a net margin of 4.66% compared to Definitive Healthcare's net margin of -72.28%. OptimizeRx's return on equity of 9.44% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Definitive Healthcare	-72.28%	3.55%	1.63%

OptimizeRx has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.34	$5.13M	$0.23	33.89
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A

In the previous week, OptimizeRx and OptimizeRx both had 3 articles in the media. OptimizeRx's average media sentiment score of 0.93 beat Definitive Healthcare's score of 0.82 indicating that OptimizeRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 7.5% of OptimizeRx shares are held by insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

OptimizeRx beats Definitive Healthcare on 11 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Health Catalyst presently has a consensus target price of $2.45, suggesting a potential upside of 37.25%. Definitive Healthcare has a consensus target price of $1.47, suggesting a potential upside of 42.17%. Given Definitive Healthcare's higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

Definitive Healthcare has a net margin of -72.28% compared to Health Catalyst's net margin of -90.61%. Definitive Healthcare's return on equity of 3.55% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Definitive Healthcare	-72.28%	3.55%	1.63%

In the previous week, Definitive Healthcare had 1 more articles in the media than Health Catalyst. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.91 beat Definitive Healthcare's score of 0.82 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Definitive Healthcare has lower revenue, but higher earnings than Health Catalyst. Definitive Healthcare is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.43	-$177.97M	-$3.68	N/A
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A

Health Catalyst has a beta of 1.53, suggesting that its share price is 53% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Definitive Healthcare beats Health Catalyst on 10 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to CareCloud?

Definitive Healthcare (NASDAQ:DH) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Definitive Healthcare has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to Definitive Healthcare's net margin of -72.28%. CareCloud's return on equity of 27.07% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
CareCloud	6.21%	27.07%	14.56%

In the previous week, Definitive Healthcare had 2 more articles in the media than CareCloud. MarketBeat recorded 3 mentions for Definitive Healthcare and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat Definitive Healthcare's score of 0.82 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
Definitive Healthcare	Positive
CareCloud	Very Positive

Definitive Healthcare currently has a consensus target price of $1.47, suggesting a potential upside of 42.17%. CareCloud has a consensus target price of $3.25, suggesting a potential upside of 54.39%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

CareCloud has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A
CareCloud	$120.50M	0.74	$10.80M	$0.07	30.07

Summary

CareCloud beats Definitive Healthcare on 12 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to DarioHealth?

DarioHealth (NASDAQ:DRIO) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

DarioHealth has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

Definitive Healthcare has a net margin of -72.28% compared to DarioHealth's net margin of -169.87%. Definitive Healthcare's return on equity of 3.55% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Definitive Healthcare	-72.28%	3.55%	1.63%

DarioHealth presently has a consensus price target of $10.00, suggesting a potential upside of 41.74%. Definitive Healthcare has a consensus price target of $1.47, suggesting a potential upside of 42.17%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

In the previous week, DarioHealth and DarioHealth both had 3 articles in the media. DarioHealth's average media sentiment score of 1.00 beat Definitive Healthcare's score of 0.82 indicating that DarioHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarioHealth	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DarioHealth has higher earnings, but lower revenue than Definitive Healthcare. DarioHealth is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	3.09	-$41.71M	-$6.13	N/A
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A

Summary

Definitive Healthcare beats DarioHealth on 11 of the 16 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DH vs. The Competition

Export

Metric	Definitive Healthcare	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$110.49M	$1.71B	$7.21B	$12.79B
Dividend Yield	N/A	4.70%	2.57%	11.71%
P/E Ratio	-0.65	20.80	274.47	25.54
Price / Sales	0.46	92.61	636.76	89.10
Price / Cash	0.53	31.57	28.42	34.96
Price / Book	0.39	6.20	10.45	6.27
Net Income	-$138.93M	-$18.66M	$3.49B	$358.19M
7 Day Performance	-1.43%	-0.07%	-2.00%	-1.14%
1 Month Performance	61.92%	2.54%	0.59%	-2.41%
1 Year Performance	-75.06%	-12.99%	24.81%	8.87%

Definitive Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DH Definitive Healthcare	3.082 of 5 stars	$1.04 -1.4%	$1.47 +42.2%	-74.7%	$110.49M	$241.52M	N/A	970	Analyst Upgrade
AMWL American Well	2.2744 of 5 stars	$13.46 +3.6%	$9.50 -29.4%	+97.1%	$222.68M	$249.32M	N/A	1,040
OPRX OptimizeRx	3.81 of 5 stars	$7.65 -2.9%	$11.43 +49.5%	-57.9%	$144.05M	$109.43M	33.24	100	News Coverage
HCAT Health Catalyst	3.1898 of 5 stars	$1.71 +0.9%	$2.45 +43.7%	-45.7%	$129.07M	$311.14M	N/A	1,200
CCLD CareCloud	3.9734 of 5 stars	$2.18 -2.5%	$3.25 +49.4%	-45.0%	$92.42M	$120.50M	31.07	3,650	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DH) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Competitors

DH vs. AMWL, OPRX, HCAT, CCLD, and DRIO

How does Definitive Healthcare compare to American Well?

Summary

How does Definitive Healthcare compare to OptimizeRx?

Summary

How does Definitive Healthcare compare to Health Catalyst?

Summary

How does Definitive Healthcare compare to CareCloud?

Summary

How does Definitive Healthcare compare to DarioHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Competitors

DH vs. AMWL, OPRX, HCAT, CCLD, and DRIO

How does Definitive Healthcare compare to American Well?

Do analysts prefer DH or AMWL?

Which has more volatility and risk, DH or AMWL?

Does the media prefer DH or AMWL?

Do institutionals & insiders hold more shares of DH or AMWL?

Is DH or AMWL more profitable?

Which has preferable earnings & valuation, DH or AMWL?

Summary

How does Definitive Healthcare compare to OptimizeRx?

Which has more volatility & risk, OPRX or DH?

Do analysts prefer OPRX or DH?

Is OPRX or DH more profitable?

Which has higher valuation & earnings, OPRX or DH?

Does the media refer more to OPRX or DH?

Do institutionals and insiders have more ownership in OPRX or DH?

Summary

How does Definitive Healthcare compare to Health Catalyst?

Do analysts recommend HCAT or DH?

Is HCAT or DH more profitable?

Does the media favor HCAT or DH?

Which has preferable earnings and valuation, HCAT or DH?

Which has more volatility & risk, HCAT or DH?

Do institutionals & insiders hold more shares of HCAT or DH?

Summary

How does Definitive Healthcare compare to CareCloud?

Do insiders & institutionals hold more shares of DH or CCLD?

Which has more volatility & risk, DH or CCLD?

Is DH or CCLD more profitable?

Does the media prefer DH or CCLD?

Do analysts recommend DH or CCLD?

Which has better valuation & earnings, DH or CCLD?

Summary

How does Definitive Healthcare compare to DarioHealth?

Do insiders and institutionals hold more shares of DRIO or DH?

Which has more volatility and risk, DRIO or DH?

Is DRIO or DH more profitable?

Do analysts prefer DRIO or DH?

Does the media favor DRIO or DH?

Which has better valuation & earnings, DRIO or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools